Applied Genetic Technologies Corporation Scientific Founders William W. Hauswirth And R. Jude Samulski Receive Pioneer Awards For Seminal Work In Gene And Cell Therapy

GAINESVILLE, Fla.--(BUSINESS WIRE)--Applied Genetic Technologies Corporation, a clinical stage biotechnology company developing adeno-associated virus (AAV)-based systems to deliver human therapeutics, today announced that two of the company’s scientific founders, William W. Hauswirth, Ph.D., University of Florida College of Medicine, and R. Jude Samulski, Ph.D., Gene Therapy Center, University of North Carolina at Chapel Hill, have been named Pioneer Award winners for their seminal work in gene and cell therapy by the peer-reviewed journal Human Gene Therapy. Dr. Hauswirth, nominated for his work in gene therapy for eye disorders, and Dr. Samulski, nominated for contributions to basic AAV vector technology, were selected by a blue ribbon panel commissioned by Human Gene Therapy to identify 12 scientists who have made influential contributions to cell and gene therapy research over an extended period of time.

Help employers find you! Check out all the jobs and post your resume.